摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

C-(2,3,4-tri-O-benzyl-β-D-xylopyranosyl)-methanol | 13121-49-8

中文名称
——
中文别名
——
英文名称
C-(2,3,4-tri-O-benzyl-β-D-xylopyranosyl)-methanol
英文别名
1,5-anhydro-2,3,4-tri-O-benzyl-D-glucitol;2,3,4-tri-O-benzyl-1,5-anhydro-D-glucitol;[(2R,3R,4R,5S)-3,4,5-tris(phenylmethoxy)oxan-2-yl]methanol
C-(2,3,4-tri-O-benzyl-β-D-xylopyranosyl)-methanol化学式
CAS
13121-49-8
化学式
C27H30O5
mdl
——
分子量
434.532
InChiKey
OKRKDAAIOOFVSA-HVWQDESWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    79 °C
  • 沸点:
    575.3±50.0 °C(Predicted)
  • 密度:
    1.20±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    32
  • 可旋转键数:
    10
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    57.2
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Synthesis and Comparative Structure–Activity Study of Carbohydrate-Based Phenolic Compounds as α-Glucosidase Inhibitors and Antioxidants
    作者:Shota Machida、Saki Mukai、Rina Kono、Megumi Funato、Hiroaki Saito、Taketo Uchiyama
    DOI:10.3390/molecules24234340
    日期:——

    Twenty-one natural and unnatural phenolic compounds containing a carbohydrate moiety were synthesized and their structure–activity relationship (SAR) was evaluated for α-glucosidase inhibition and antioxidative activity. Varying the position of the galloyl unit on the 1,5-anhydro-d-glucitol (1,5-AG) core resulted in changes in the α-glucosidase inhibitory activity and notably, particularly strong activity was demonstrated when the galloyl unit was present at the C-2 position. Furthermore, increasing the number of the galloyl units significantly affected the α-glucosidase inhibition, and 2,3,4,6-tetra-galloyl-1,5-AG (54) and 2,3,4,6-tetra-galloyl-d-glucopyranose (61) exhibited excellent activities, which were more than 13-fold higher than the α-glucosidase inhibitory activity of acertannin (37). Moreover, a comparative structure-activity study suggested that a hemiacetal hydroxyl functionality in the carbohydrate core and a biaryl bond of the 4,6-O-hexahydroxydiphenoyl (HHDP) group, which are components of ellagitannins including tellimagrandin I, are not necessary for the α-glucosidase inhibitory activity. Lastly, the antioxidant activity increased proportionally with the number of galloyl units.

    合成了二十一种含有碳水化合物基团的天然和非天然酚类化合物,并评估了它们在α-葡萄糖苷酶抑制和抗氧化活性方面的结构-活性关系(SAR)。在1,5-脱氧-D-葡萄糖醇(1,5-AG)核心上改变没食子酸单元的位置导致了α-葡萄糖苷酶抑制活性的变化,特别是当没食子酸单元位于C-2位置时表现出明显的强活性。此外,增加没食子酸单元的数量显著影响了α-葡萄糖苷酶抑制作用,2,3,4,6-四没食子酸-1,5-AG(54)和2,3,4,6-四没食子酸-D-葡萄糖吡喃糖(61)表现出卓越的活性,其α-葡萄糖苷酶抑制活性比没食子酸(37)高出13倍以上。此外,一项比较结构-活性研究表明,碳水化合物核心中的半缩醛羟基官能团和4,6-O-六羟基二苯甲酰(HHDP)单元的双芳基键,包括tellimagrandin I在内的椰子酸鞣质并不是α-葡萄糖苷酶抑制活性所必需的。最后,抗氧化活性随没食子酸单元数量的增加而成比例增加。
  • Triisobutylaluminium and Diisobutylaluminium Hydride as Molecular Scalpels: The Regioselective Stripping of Perbenzylated Sugars and Cyclodextrins
    作者:Thomas Lecourt、Alexandre Herault、Alan J. Pearce、Matthieu Sollogoub、Pierre Sinaÿ
    DOI:10.1002/chem.200305683
    日期:2004.6.21
    mechanistic rationale critically involving the kinetic formation of a product-generating 2:1 Al-benzylated sugar complex. For the reaction to occur, one pair of adjacent oxygen atoms should first be able to form a chelation complex with the first equivalent of aluminium reagent, either a highly fluxional complex with tetracoordinate aluminium species or a pentacoordinate one. The second equivalent then
    为了解释氢化二异丁基铝(DIBAL-H)和三异丁基铝(TIBAL)对聚苄基糖或环糊精具有显着的区域选择性脱O-苄基化性能,我们提出了一种合理的机理原理,主要涉及动力学生成产物2:1 Al的动力学形成-苄基糖复合物。为使反应发生,一对相邻的氧原子应首先能够与第一当量的铝试剂形成螯合络合物,该络合物可以是具有四配位铝物种的高通量配位化合物,也可以是五配位铝原子的高通量配位化合物。然后,第二个等价物通过优先与所选对中的一个氧原子配位,诱导脱-O-烷基化的区域选择性。
  • C,O-SPIRO ARYL GLYCOSIDE COMPOUNDS, PREPARATION THEREFOR AND USE THEREOF
    申请人:Shanghai Institute of Materia Medica, Chinese Academy of Sciences
    公开号:EP3315502A1
    公开(公告)日:2018-05-02
    The present invention provides C, O-spiro aryl glycoside compounds, preparation therefor and use thereof. Specifically provided are the compounds represented by the formula (I), wherein the definitions of each group are described in the specification. The compound can be used as SGLT2 inhibitors in preparing the pharmaceutical compositions for treating diseases such as diabetes, atherosclerosis, adiposity and etc.
    本发明提供了 C、O-螺芳基苷化合物、其制备方法及其用途。具体提供了由式(I)表示的化合物,其中各组的定义在说明书中描述。该化合物可作为 SGLT2 抑制剂用于制备治疗糖尿病、动脉粥样硬化、脂肪肝等疾病的药物组合物。
  • The temporary silicon connection method in the control of regio- and stereochemistry. Applications to radical-mediated reactions. The stereospecific synthesis of C-glycosides
    作者:Gilbert Stork、Hong Suk Suh、Guncheol Kim
    DOI:10.1021/ja00018a063
    日期:1991.8
  • Ginnalin B induces differentiation markers and modulates the proliferation/differentiation balance via the upregulation of NOTCH1 in human epidermal keratinocytes
    作者:Atsushi Kato、Junna Koyama、Kenta Shinzawa、Shuki Imaeda、Isao Adachi、Robert J. Nash、George W.J. Fleet、Megumi Shintani、Chihiro Takeuchi、Fumihiro Ishikawa
    DOI:10.1016/j.bmc.2019.04.008
    日期:2019.6
    The red maple and sugar maple (Acer rubrum and A. saccharum, respectively) contain acertannins (ginnalins and maplexins), galloylated derivatives of 1,5-anhydro-D-glucitol (1,5-AG, 1). These compounds have a variety of potential medicinal properties and we have shown that some of them promote the expression of ceramide synthase 3. We now report on the beneficial effects of ginnalin B, (6-O-galloyl-1,5-AG, 5), leading to acceleration of skin metabolism and reduction of the turnover time. Ginnalin B dose-dependently increased the relative amount of keratin 10, keratin 1, and filaggrin gene, with maximal increase of 1.7-, 2.9, and 5.2-fold at 100 mu M, respectively. The validation study showed that it had superior capacity to induce multiple stages of keratinocyte differentiation and significantly elevated the immunostaining site of keratin 10 and filaggrin in a 3-dimensional cultured human skin model, by 1.2 and 2.8-fold, respectively. Furthermore, ginnalin B caused the arrest of proliferation at the G(0)/G(1) phase but it did not induce apoptotic cell death in normal human keratinocytes. Molecular studies revealed that ginnalin B up-regulated the levels of NOTCH1 and a concomitant increase p21 expression. Ginnalin B, therefore, represents a new class of promising functional and medical cosmetic compound and it could contribute to the maintenance of homeostasis of the epidermis.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐